Patent details

EP3231798 Title: COMPOUNDS FOR PREPARING RAF KINASE INHIBITORS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3231798
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17168722.1
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
30/06/2008
Grant date:
09/10/2019
EP Publication Date:
18/10/2017
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
17/12/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
09/10/2019
EP B1 Publication Date:
09/10/2019
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
29/06/2028
Lapsed By Expiration Date:
Patent Validated Date:
23/01/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
25/07/2022
 
 

 

Name:
Sunesis Pharmaceuticals, Inc.
Address:
395 Oyster Point Blvd., Suite 400, SOUTH SAN FRANCISCO, CA 94080, United States of America (US)

From:
25/07/2022
 
 

 

Name:
DOT Therapeutics-1, Inc
Address:
2765 Sand Hill Road, 94025, Menlo Park, CA, United States of America (US)

Historical Applicant/holder

From:
09/10/2019
To:
25/07/2022

 

Name:
Sunesis Pharmaceuticals, Inc.
Address:
395 Oyster Point Blvd., Suite 400, SOUTH SAN FRANCISCO, CA 94080, United States of America (US)

From:
09/10/2019
To:
25/07/2022

 

Name:
Millennium Pharmaceuticals, Inc.
Address:
40 Landsdowne Street, CAMBRIDGE, MA 02139, United States of America (US)

Agent

Name:
M.L. Huisman
From:
22/01/2020
Address:
Huisman Advocaten Postbus 130, 4460 AC, Goes, Netherlands (NL)
To:

Inventor

1

Name:
CHEN, Weirong
Address:
Cambridge, MA 02142, United States of America (US)

2

Name:
COSSROW, Jennifer
Address:
San Mateo, CA 94404, United States of America (US)

3

Name:
FRANKLIN, Lioyd
Address:
Upton, MA 01568, United States of America (US)

4

Name:
GUAN, Bing
Address:
Needham, MA 02494, United States of America (US)

5

Name:
JONES, John, Howard
Address:
Framingham, MA 01701, United States of America (US)

6

Name:
KUMARAVEL, Gnanasambandam
Address:
Westford, MA 01886, United States of America (US)

7

Name:
LANE, Benjamin
Address:
Chelsea, MA 02150, United States of America (US)

8

Name:
LITTKE, Adam
Address:
Cambridge, MA 02142, United States of America (US)

9

Name:
LUGOVSKOY, Alexey
Address:
Cambridge, MA 02142, United States of America (US)

10

Name:
PENG, Hairuo
Address:
Needham, MA 02494, United States of America (US)

11

Name:
POWELL, Noel
Address:
Westford, MA 01886, United States of America (US)

12

Name:
RAIMUNDO, Brian
Address:
San Francisco, CA 94116, United States of America (US)

13

Name:
TANAKA, Hiroko
Address:
South San Francisco, CA 94080, United States of America (US)

14

Name:
VESSELS, Jeffrey
Address:
Marlborough, MA 01752, United States of America (US)

15

Name:
WYNN, Thomas
Address:
Salem, MA 01970, United States of America (US)

16

Name:
XIN, Zhili
Address:
Lexington, MA 02420, United States of America (US)

Priority

Priority Patent Number:
947291 P
Priority Date:
29/06/2007
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/506; A61P 29/00; A61P 35/00; C07D 401/12; C07D 401/14; C07D 403/12; C07D 413/14; C07D 417/12; C07D 417/14; C07D 471/04; C07D 473/00; C07D 487/04;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
32/22
Publication date:
10/08/2022
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
05/20
Publication date:
29/01/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
41/19
Publication date:
09/10/2019
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201942
Publication date:
16/10/2019
Description:
Title of invention Modified

2

Issue number:
201941
Publication date:
09/10/2019
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202201853A
Date Registered:
25/07/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Bureau M.F.J. Bockstael NV/SA
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Sunesis Pharmaceuticals, Inc.
Address:
395 Oyster Point Blvd., Suite 400, SOUTH SAN FRANCISCO, CA 94080, United States of America (US)

2

Name:
DOT Therapeutics-1, Inc
Address:
2765 Sand Hill Road, 94025, Menlo Park, CA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/06/2026
Annual Fee Number:
19
Annual Fee Amount:
1300 Euro
Last Annual Payment Date:
26/06/2025
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
1200 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
22/01/2020 Outgoing Correspondence Letter no formal defects 1 PDF /6/7/2/0/7/0800470276/docs/ep17168722.1_1_321811l271.pdf
17/12/2019 Claims First filed claims 3 PDF /6/7/2/0/7/0800470276/docs/ep17168722.1_0_claims20191217161642864.pdf